Premium
Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma
Author(s) -
Kavanagh Joanne E.,
Hearn Andrew P.,
d’Ancona Grainne,
Dhariwal Jaideep,
Roxas Cris,
Green Linda,
Thomson Louise,
Fernandes Mariana,
Kent Brian D.,
Nanzer Alexandra M.,
Jackson David J.
Publication year - 2021
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.14693
Subject(s) - mepolizumab , medicine , benralizumab , exacerbation , prednisone , asthma , eosinophil
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom